Literature DB >> 10706676

Normal lymphoid homeostasis and lack of lethal autoimmunity in mice containing mature T cells with severely impaired IL-2 receptors.

T R Malek1, B O Porter, E K Codias, P Scibelli, A Yu.   

Abstract

The importance of IL-2Rbeta function for immune regulation is highlighted by the severe impairment in lymphoid cell function in IL-2Rbeta-deficient mice. It has been speculated that failed IL-2/IL-2R signaling in peripheral T cells causes the associated autoimmunity, imbalanced peripheral lymphoid homeostasis, and defective T cell function. This study explored the requirement for IL-2Rbeta function in mature T lymphocytes. We show that transgenic thymic expression of the IL-2R beta-chain in IL-2Rbeta-deficient mice prevents lethal autoimmunity, restores normal production of B lymphocytes, and results in a peripheral T cell compartment that is responsive to triggering through the TCR, but not the IL-2R. The dysfunction of the IL-2R is illustrated by the near complete failure of mature T cells to proliferate to IL-2 in vitro and in vivo, to differentiate into CTL, and to up-regulate IL-2Ralpha expression. These data indicate that lymphoid homeostasis is largely maintained despite a nonfunctional IL-2R in mature T lymphocytes and suggest that IL-2Rbeta provides an essential signal during thymic development to regulate self-reactivity.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10706676     DOI: 10.4049/jimmunol.164.6.2905

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  45 in total

1.  Spontaneous autoimmunity in the absence of IL-2 is driven by uncontrolled dendritic cells.

Authors:  Sara H Isakson; Shoshana D Katzman; Katrina K Hoyer
Journal:  J Immunol       Date:  2012-07-09       Impact factor: 5.422

2.  Therapeutic Treg expansion in mice by TNFRSF25 prevents allergic lung inflammation.

Authors:  Taylor H Schreiber; Dietlinde Wolf; Matthew S Tsai; Jackie Chirinos; Vadim V Deyev; Louis Gonzalez; Thomas R Malek; Robert B Levy; Eckhard R Podack
Journal:  J Clin Invest       Date:  2010-09-20       Impact factor: 14.808

3.  Nonredundant roles for Stat5a/b in directly regulating Foxp3.

Authors:  Zhengju Yao; Yuka Kanno; Marc Kerenyi; Geoffrey Stephens; Lydia Durant; Wendy T Watford; Arian Laurence; Gertraud W Robinson; Ethan M Shevach; Richard Moriggl; Lothar Hennighausen; Changyou Wu; John J O'Shea
Journal:  Blood       Date:  2007-01-16       Impact factor: 22.113

Review 4.  The T-cell receptor repertoire of regulatory T cells.

Authors:  Rafal Pacholczyk; Joanna Kern
Journal:  Immunology       Date:  2008-12       Impact factor: 7.397

5.  Allogeneic T regulatory cell-mediated transplantation tolerance in adoptive therapy depends on dominant peripheral suppression and central tolerance.

Authors:  Dennis Adeegbe; Robert B Levy; Thomas R Malek
Journal:  Blood       Date:  2009-12-29       Impact factor: 22.113

Review 6.  Pro- and anti-inflammatory cytokines in cutaneous leishmaniasis: a review.

Authors:  Nahid Maspi; Amir Abdoli; Fathemeh Ghaffarifar
Journal:  Pathog Glob Health       Date:  2016-09-23       Impact factor: 2.894

Review 7.  The IL-2/IL-2R system: from basic science to therapeutic applications to enhance immune regulation.

Authors:  Allison L Bayer; Alberto Pugliese; Thomas R Malek
Journal:  Immunol Res       Date:  2013-12       Impact factor: 2.829

8.  A function for IL-7R for CD4+CD25+Foxp3+ T regulatory cells.

Authors:  Allison L Bayer; Joon Youb Lee; Anabel de la Barrera; Charles D Surh; Thomas R Malek
Journal:  J Immunol       Date:  2008-07-01       Impact factor: 5.422

Review 9.  Exploring the Pathogenic Role and Therapeutic Implications of Interleukin 2 in Autoimmune Hepatitis.

Authors:  Albert J Czaja
Journal:  Dig Dis Sci       Date:  2020-08-24       Impact factor: 3.199

10.  A low interleukin-2 receptor signaling threshold supports the development and homeostasis of T regulatory cells.

Authors:  Aixin Yu; Linjian Zhu; Norman H Altman; Thomas R Malek
Journal:  Immunity       Date:  2009-01-29       Impact factor: 31.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.